developing an hl7 fhir implementation guide for rare cancers the idea4rc project experience

Original title: “Developing an HL7 FHIR Implementation Guide for Rare Cancers: The IDEA4RC Project Experience.”

The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that AVLAYAH (tividenofusp alfa-eknm), approve

Original title: “Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm)”

diagnostic utility of clinical genome reanalysis in rare pediatric disorders using long read sequencing

Original title: “Diagnostic utility of clinical genome reanalysis in rare pediatric disorders using long-read sequencing.”

diagnostic yield and genetic landscape of rare pediatric diseases in vietnam identified by exome sequencing

Original title: “Diagnostic yield and genetic landscape of rare pediatric diseases in Vietnam identified by exome sequencing.”

boosting pathology foundation models via few shot prompt tuning for rare cancer subtyping

Original title: “Boosting pathology foundation models via few-shot prompt-tuning for rare cancer subtyping.”